# Cystatin C as an Early Marker of Contrast-Medium Nephropathy in Cardiac Catheterization Patients

> **NCT00467311** · — · COMPLETED · sponsor: **National Heart Institute, Mexico** · enrollment: 66 (actual)

## Conditions studied

- Contrast Induced Nephropathy
- Acute Renal Failure

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00467311
- **Lead sponsor:** National Heart Institute, Mexico
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2007-12
- **Final completion:** 2008-04
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2008-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00467311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00467311, "Cystatin C as an Early Marker of Contrast-Medium Nephropathy in Cardiac Catheterization Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00467311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*